Stephen Saad’s stake in Africa’s largest pharmaceutical company sinks below $600 million
South African pharmaceutical tycoon Stephen Saad faces setback as Aspen Pharmacare shares decline.
Related
Aspen Pharmacare founder Stephen Saad eyes Canada as first proving ground for generic Ozempic rivals
Aspen founder Stephen Saad wants Canada to be the proving ground for generic semaglutide, as competitors race regulators and supply constraints.
South African pharma tycoon Stephen Saad’s Aspen to sell Asia-Pacific assets for $1.59 billion
Stephen Saad’s Aspen will sell most Asia-Pacific operations for $1.59 billion as the drugmaker trims debt and reshapes its global footprint.
South African tycoon Stephen Saad loses $19 million from Aspen stake
Stephen Saad’s Aspen Pharmacare stake loses $19 million as shares fall, highlighting mounting pressure on Africa’s largest drugmaker.
South African tycoon Stephen Saad’s Aspen stake loses $18 million
Stephen Saad’s Aspen stake drops $18 million as shares fall 5.45% in 16 days, deepening losses for South Africa’s largest drugmaker.
Latest
Burkinabe mogul Idrissa Nassa looks to establish Coris Bank in Gabon
Idrissa Nassa met Gabon’s president as Coris Bank confirmed plans to expand into the country and finance priority projects.
Africa's richest man says Dangote Refinery IPO could happen before July
Aliko Dangote says Nigerians may be able to buy shares in his refinery by July, opening the project to wider local ownership.
Tunisian businessman Abdelwaheb Ben Ayed’s Poulina Group moves ahead with bid for cheese maker LandOr
Poulina Group Holding has launched a bid for a majority stake in LandOr, signaling a new push to strengthen its agri food business.
Egyptian billionaire Naguib Sawiris says anger cost him €500 million in failed investment bet
Naguib Sawiris says an angry investment decision wiped out €500 million, as the Egyptian billionaire reflects on risk and discipline.